Diabetic Footwear Market size is slated to cross USD 18 Billion by the end of 2033, growing at a CAGR of 11% during the forecast period, i.e., 2023-2033. In the year 2022, the industry size of diabetic footwear was over USD 8 Billion. The growth of the market is primarily attributed to the worldwide increasing prevalence of diabetes. Moreover, these footwears are becoming popular among the people suffering from diabetes, as it reduces the risk of skin damage, and it is anticipated to increase the growth of the global diabetic footwear market. According to the data released by the World Health Organization (WHO), approximately 422 million people are currently suffering from diabetes worldwide, and this disease is directly responsible for 1.5 million deaths each year.
Diabetic footwear (shoes) is specially crafted footwear that protects the feet of diabetic patients. The growth of diabetic footwear is being fueled by the fact that this footwear offers support and protection while minimizing pressure points on the feet, lowers the risk of diabetic foot ulcers, and thereby reduces amputations, etc. It also helps to heal several diabetic conditions, such as poor blood circulation in the legs, and also addresses foot pain and ulcers. Moreover, people with diabetes have a higher risk of experiencing deep vein thrombosis (DVT). Thus, diabetic shoes are used to lessen the consequences of DVT. According to the Centers for Disease Control and Prevention (CDC), in the United States, almost 900,000 people are directly affected by deep vein thrombosis (DVT) each year.
Growth Drivers
Challenges
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
11% |
|
Base Year Market Size (2022) |
USD 8 Billion |
|
Forecast Year Market Size (2033) |
USD 18 Billion |
|
Regional Scope |
|
End-user (Male, Female)
The diabetic footwear (shoes) market is segmented and analyzed for demand and supply by end-user into males and females. Out of these, the female segment is anticipated to significantly grow over the forecast period owing to the rapidly increasing count of female diabetic patients across the globe, and rising awareness in females regarding the effects of diabetes. Furthermore, the customizable diabetic footwear are popular among the women in order to have latest fashions, and it is expected to increase the segment’s growth in the market. For instance, it was observed in research, in the major cities of India, until 2021, the lifetime diabetes risk for 20-year-old men has increased nearly by 54%, whereas this ratio has raised around 66% for women, and it was especially high among obese women with a ratio of approximately 87%.
Distribution Channel {Online (E-commerce, Company Owned Websites), Offline (Shoe Stores, Departmental, Medical Specialty Stores)}
The global diabetic footwear market is also segmented and analyzed for demand and supply by distribution channel into online and offline. As buyers can personally inspect and try on things before buying, offline platforms such as retail outlets are anticipated to hold a higher portion of the market. This is significant for diabetic footwear since the comfort and fitting of the footwear are essential for avoiding foot problems. Online distribution methods, such as e-commerce platforms, are also anticipated to gain traction since they provide ease and a greater selection of goods. Customers may compare prices and items conveniently through online platforms as well. For instance, it is estimated that around 20 billion pairs of shoes are sold every year. Moreover, it has been found that 3 in 4 people prefer buying shoes online presently.
Our in-depth analysis of the global diabetic footwear market includes the following segments:
|
By Type |
|
|
By Width |
|
|
By Patient Type |
|
|
By Price Range |
|
|
By Distribution Channel |
|
|
By End-User
|
|
North America Market Forecast
The North America diabetic footwear market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033 backed by the increasing prevalence of diabetes, and the significantly increasing geriatric population in the region. Moreover, there has been a rising awareness among people related to diabetics and the use of footwear for the comfort of the foot, and it is predicted to increase the market’s growth in the region. As per a report provided by the Centers for Disease Control and Prevention (CDC), in the United States, diabetes affects approximately 37.3 million people, which represents nearly 11% of the US population. Moreover, the diabetic ulcer treatment recommended by the doctors includes wearing footwear that reduces the pain of the patients, followed by the rising number of people suffering from the chronic pain in the North America region, and it is expected to boost the market’s growth in the region.
DARCO International, Inc. and Sensoria Health partnered to jointly develop smart diabetic footwear that is powered by mobile and cloud-based patient monitoring technology. This partnership is anticipated to lead to innovation in the podiatry field.
DJO Global, Inc. has acquired orthopedic medical device company MedShape, Inc. With its patented superelastic nickel-titanium alloy (NiTiNOL) and shape memory polymer technology, MedShape offers innovative surgical solutions for foot and ankle surgeons.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?